Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Equities

Eve Health Group Ltd

EVE:ASX

Eve Health Group Ltd

Actions
Basic MaterialsIndustrial Metals and Mining
  • Price (AUD)0.001
  • Today's Change0.00 / 0.00%
  • Shares traded19.63k
  • 1 Year change0.00%
  • Beta0.4793
Data delayed at least 20 minutes, as of Nov 03 2024 23:02 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

EVE Health Group Limited is an Australia-based vertically integrated producer of branded nutrition, health and wellness products. The Company’s Meluka business provides branded wellness consumer products. Its Meluka business is focused on supporting sales of its digestive health products, in particular the P3 Gut Builder. It provides probiotic supplement powder system for improved digestive health. The functional gut nutrition solution is in the form of a three-step supplement powder system, each of which contain pre, pro and postbiotics as well as selected functional superfood ingredients in an easy to consume and versatile offering. The Company also offers honey and essential oil products. Its honey products include organic raw honey and raw honey probiotic concentrate. The Company has global reach and application to various markets across Australia and New Zealand, Asia Pacific and North America.

  • Revenue in AUD (TTM)2.13m
  • Net income in AUD-1.55m
  • Incorporated2003
  • Employees--
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Eve Health Group Ltd2.13m-1.55m5.27m----4.31--2.47-0.0003-0.00040.00040.00020.6413.7821.95---46.53-34.28-71.22-38.3241.1040.00-72.58-129.881.83--0.0576---8.455.9534.08------
Oliver's Real Food Ltd26.67m-2.31m5.29m--------0.1983-0.005-0.0050.0605-0.042.2125.54283.02---19.16-35.74-51.06-63.0063.1761.80-8.67-27.300.0799-0.2632.79--7.09-5.27-139.26--6.38--
Elixinol Wellness Ltd11.68m-6.87m6.24m----0.7109--0.5342-0.0083-0.00830.01340.00560.96222.514.84---56.56-77.11-83.45-84.5937.4949.78-58.78-308.550.9185-38.230.1372--19.85-25.7428.98---67.79--
Wellnex Life Ltd16.65m-13.74m18.51m----2.81--1.11-1.13-1.130.97880.2350.72443.713.75---59.78-110.69-398.81-188.9125.8113.75-82.53-184.640.2529-3.940.6377---40.3072.330.7728------
Star Combo Pharma Ltd26.28m747.34k20.26m--22.730.60811.110.7710.00660.00660.26550.24670.6183.855.99--1.76-5.571.98-6.1922.7417.012.84-8.612.476.480.1073--5.164.01118.67---19.40--
Maggie Beer Holdings Ltd89.73m-28.24m20.54m76.00--0.3538--0.2289-0.0806-0.08060.25460.16390.99773.5111.63---31.40-7.48-36.82-8.4848.4949.93-31.47-10.821.07-34.490.088--1.0228.36-3,786.42--15.42--
Data as of Nov 03 2024. Currency figures normalised to Eve Health Group Ltd's reporting currency: Australian Dollar AUD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.